Skip to main content

Aquestive Therapeutics, Inc.

AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001398733

In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Aquestive Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of AQST: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders6046−14
Shares15.6M14.8M−847.0K (−5.4%)
Value$62.0M$64.4M+$2.40M (+3.9%)

New holders (5)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to AQST in Q3 2021
InstitutionSharesValue% of portfolio
Balyasny Asset Management LLC148,061$646.0K0.00%
Citadel Advisors LLC41,711$182.0K0.00%
Migdal Insurance & Financial Holdings Ltd.2,406$10.0K0.00%
Quantbot Technologies LP1,400$6.00K0.00%
Strategic Asset Management, LLC50$00.00%

Sold out (19)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.